Cannabidiol (CBD) is a cannabinoid compound derived from Cannabis .. ) and in overall functioning (GAF: treatment difference=, 95% CI=, ). that CBD's reversal of the MK effects on PPI is unlikely to stem from a direct. and cannabidiol (CBD) both alone and in combination with radiotherapy in a number of glioma cell lines. (T98G, U87MG . % THC, % CBD, % CBG, % CBC, % THCV, .. mode of action of the cannabinoids stems from the. Read reviews on the Cherry Hill (High Voltage CBD) Strain submitted by Lift & Co . THC % The CBD-rich, indica-dominant hybrid High Voltage has dense, tightly formed buds, covered in light green leaves, a thick layer of orange pistils.
Stems 0.4% CBD CBD
We do expect a small percentage of vaporizer cartridges to fail. We are happy to exchange defective cartridges or batteries. Please bring the defective item and original receipt if possible with you on your next visit to the dispensary.
We are sorry for any inconvenience caused by defective products. Sorry, the sale of seeds and plants is not allowed at this time.
The following articles have been compiled here for your convenience. ATG has no affiliation with the providers of this content, nor do we take responsibility for the accuracy of this third-party content. Please consult with your physician before making decisions about your health. ATG is pleased to be hiring qualified candidates for: Sign me up to receive announcements and updates from ATG. All the potency and flavor of shatter without the carcinogens!
High quality cannabis infused edible and topical products. Flower Edibles Topicals Concentrates. This renowned hybrid is known for its potency and flavors of sweet honey, flower, and spice. This pure African landrace strain is known for a clear-headed, energizing effect which is commonly used to treat depression, anxiety, and PTSD. Flavors are dank, sweet and faintly like licorice. Slazerbeam is the perfect choice for patients suffering from conditions such as depression, chronic pain, fatigue, and muscle spasms.
Slazerbeam has a deliciously citrus flavor with hints of spicy earth and herbal tea. Sativa-dominant strain from the Chemdawg family known for a sweet, fruity and citrus aroma. Patients typically choose this strain for daytime relief of stress and tension. Legendary, sativa-dominant strain known for its fast-acting, invigorating effect and pungent, diesel-like fragrance.
Sativa-dominant hybrid with sour citrus aromas and flavors of earthy Skunk, known to produce happy thoughts and a smile that lasts all day. Sativa-dominant effects which are uplifting and recommended for creative stimulation. Noted for sour, skunky smell with hints of fresh fruit and flowers. Brother Jonathan's Alchemy indica tincture.
Each 1 ml serving size contains 10 mg of cannabis oil. Brother Jonathan's Alchemy sativa tincture. Brother Jonathan's Alchemy indica milk chocolates. Each package contains six servings. Each serving contains 10 mg of cannabis oil. Brother Jonathan's Alchemy sativa milk chocolates. Brother Jonathan's Alchemy indica dark chocolates. Brother Jonathan's Alchemy indica white chocolates. Brother Jonathan's Alchemy sativa white chocolates. Brother Jonathan's Alchemy indica gelcap capsules.
Each package contains 30 capsules. Each capsule contains 10 mg of cannabis oil. Brother Jonathan's Alchemy sativa gelcap capsules. Each capsule contains 10mg of cannabis oil. Brother Jonathan's Alchemy Lemon flavored indica lozenges. Each package contains 15 servings. Each serving contains 10 mg of cannabis oil per lozenge. Our Terpene-Rich Distillate offers the perfect blend of same-strain, same-batch cannabis terpenes for ultimate purity and taste.
High CBD strain used to treat pain, anxiety, epilepsy, multiple sclerosis, and negative effects of chemotherapy - all without intoxication. The fragrance is of sweet caramel notes, berry and hops. The effects are relaxing, anxiety-reducing and generally pleasant. Dakini Kush is commonly used for pain, sleep, anxiety, mood elevation, and appetite stimulation.
Noted for its grape and berry aroma, dense bud structure, and potent psychoactive effects. Used for relaxation, anxiety, pain, stress, insomnia, appetite stimulation, and muscle spasms. Sativa dominant hybrid known for its potency and aromas of fresh apple and mango, with a taste of pineapple, pine, and cedar.
Tangie is known for its strong, sweet flavor reminiscent of tangerines and other citrus fruits. It's good for treating several disorders like nausea, anxiety, lack of appetite, and depression. Noted for aromas of lemon, lime, and cream flavors.
Commonly used for stubborn aches, pains, nausea, and appetite loss. Known for its sweet flavor, and potency. Commonly used for pain relief, relaxation, nausea, appetite stimulation and stress reduction. Noted for an uplifting, energetic effect and flavor profile which is citrus, lemon and earthy. Star Pupil is a unique, potent, consistently purple hybrid. Crossing outstanding genetics of Thai and Afghan origin. Heavy cerebral effects and physically relaxing, this strain has special properties against muscle and stomach problems medicinally, as well as general pain relief.
Several decades later, in , the chemical structure of THC was discovered and synthesized for the first time Professor Raphael Mechoulam, Hebrew University of Jerusalem [ 67 ]. Thereafter, and coinciding with its progressive decriminalization, the interest for its potential therapeutic effects resurged. In the 90's, the discovery of several compounds: Later, in , the indication of dronabinol was extended to the treatment of patients suffering from HIV-associated anorexia.
Further on, other drug regulatory authorities approved the commercialization of other cannabinoid drugs. Rimonabant was the first cannabinoid indicated in patients with overweight and obesity for reducing appetite but it was taken off the market in , after detecting a significant increase in the risk of mental disorders, and the notification of five cases of suicide [ 68 ]. Currently, commercialized cannabinoid drugs differ depending on the country.
In the UK and the USA, dronabinol and nabilone, while nabiximols can be prescribed in many countries of the European Union, and in Canada, as already mentioned [ 69 , 71 ].
Different molecules in the process of development have also fallen into the same category: The potential therapeutic effect of CBD is also being evaluated for the treatment of Parkinson's disease, anxiety disorder, multiple sclerosis, substance use disorder, post-traumatic stress disorder, graft-versus-host disease, among others [ 16 , 21 , 22 , 76 ].
In addition, they are also being studied in several neurodegenerative, psychiatric, oncological, ophthalmological and dermatological diseases, among others [ 77 ]. Information about adverse reactions and intoxications associated with the consumption of SCs is limited mainly because it is difficult to find biological matrices in acute care areas currently there are no commercial fast diagnostic kits and because of the constant emergence of new SCs.
Even so, the general toxicity profile of SCs is presumably similar to high-potency cannabis characterized by more potent and long-lasting effects [ 50 ].
In this regard, there are epidemiological and toxicological data coming from surveys, poison centers, intoxication registers, clinical cases and case series. Data reported suggest that severe adverse reactions and fatal intoxications are much more common with SCs than with cannabis probably linked to high potency and the unintentionally high doses used [ 50 , 51 , 83 , 84 ].
These data coincide with cases of acute poisoning in patients seen in the Emergency department, who typically have psychiatric agitation, anxiety, panic attacks, psychotic symptoms, hallucinations , cardiovascular tachycardia, hypertension and chest pain , gastrointestinal nausea, vomiting and neurological symptoms decreased level of consciousness [ 79 - 82 ].
Most of them are quickly solved hours with symptomatic medical treatment. However, among serious and life-threatening complications, the following have been described: SCs in comparison to cannabis have been described have high-risk of developing psychosis especially in young individuals [ 50 , 51 , 83 , 84 ]. Importantly, evidence indicates that SCs use impairs executive functions [ 51 , 85 ].
In addition to outbreaks occurred in Europe, clinical patterns affecting dozens of SC users have been recently described in areas of American cities like New York [ 86 ]. According to these data, more than half of daily and weekly SC users talk about withdrawal, which is described as being similar to the one from cannabis [ 87 - 89 ].
Based on the available limited evidence, it is suggested that SCs, in comparison with cannabis, have greater cardiac and neurological toxicity.
Severe adverse reactions of currently marketed pharmaceutical cannabinoids have not been recorded. The adverse reactions most often described are mild to moderate, with dizziness, fatigue, ataxia, and difficulty concentrating. However, in , the emergence of several very serious adverse reactions was reported following the experimental administration of a cannabinoid drug in phase I study in Rennes France.
Previously, this drug had been administered in a single dose 0. Brain death was observed in one of them, two recovered with sequelae one subject with residual memory impairment, and the other one with residual cerebellar syndrome , and one recovered without sequelae.
The nuclear magnetic resonance imaging study revealed irreversible brain damage, hemorrhage and necrosis [ 96 ]. According to the research carried out, it has been suggested that several factors might have contributed to the dramatic event, such as low drug specificity and reversibility high inhibition , impact on the immune system, dose calculation, cumulative toxicity, off-target effects, drug impurities, and human error [ 97 ].
Currently, the mechanisms involved in the neurotoxicity of BIA are unknown exactly, but experimental studies are trying to elucidate the possible etiology [ 98 - 99 ]. A recent paper in human cells using an activity-based protein profiling, suggests that BIA , besides acting as an irreversible FAAH inhibitor, could alter neuronal lipid metabolism by inhibition of PNPLA6, an off-target protein. Although, right now, there is no causal relationship and there are many unknowns to be solved, it has been postulated that the risk of cerebral toxicity could depend on the biological species being studied.
This is the reason why toxicity was not observed in preclinical studies performed in rats and mice [ ]. There are currently several laboratories that are investigating in the same vein. Right now, there isn't any marketed endocannabinoid drug acting specifically through this pathway. The use of cannabis and, in general, cannabinoids has spread in recent years. It should be noted that the synthetic cannabinoids and the medical cannabis phenomena have opened the debate on their legalization in recreational and, especially, medical terms.
To this day, both aspects continue to be a topic of great interest in public health and clinical medicine. World Drug Report European Drug Report Bifulco M, Pisanti S. Medicinal use of cannabis in Europe: Cannabis social clubs in Belgium: Int J Drug Policy. The legalization of cannabis derivatives in Spain: Hypothesis on a potential emerging market.
Illicit drug policy in Spain: Cannabis, from plant to pill. Br J Clin Pharmacol. The Plant of the Thousand and One Molecules. Psychoactive constituents of cannabis and their clinical implications: Cannabis; Epidemiological, Neurobiological and Psychopathological Issues: Russo EB, Marcu J. Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
N Engl J Med. Cannabidiol in patients with treatment-resistant epilepsy: Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome. Perspectives on cannabis controversies, treatment and regulation in Europe. Analysis of Current Data in the United States. Analysis of cannabis seizures in NSW, Australia: High-potency cannabis increases the risk of psychosis.
Evid Based Ment Health. A case of butane hash oil marijuana wax -induced psychosis. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: Hall W, Degenhardt L.
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: Cannabis-induced psychosis associated with high potency "wax dabs". Evaluation of a vaporizing device Volcano for the pulmonary administration of tetrahydrocannabinol. CanniMed - Canada's Medical Marijuana. Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry.
Clin Chem Lab Med. Market analysis of synthetic drugs. Amphetamine-type stimulants, new psychoactive substances. Cannabis classification and Public Health. Synthetic Drug Abuse Prevention Act of El portal de Energy Control. Tai S, Fantegrossi WE. Pharmacology, Behavioral Effects, and Abuse Potential. Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH, a Spice cannabinoid.
Am J Med Sci. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM regarding its chemistry and metabolism. The detection of the urinary metabolites of 1-[ 5-fluoropentyl -1H-indolyl]- 2-iodophenyl methanone AM , a high affinity cannabimimetic, by gas chromatography - mass spectrometry. The detection of the urinary metabolites of 3-[ adamantanyl carbonyl]pentylindole AB , a novel cannabimimetic, by gas chromatography-mass spectrometry.
A Synthetic Cannabinoid Primer K Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalenyl- 1-pentylindolyl methanone JWH in human serum by liquid chromatography-tandem mass spectrometry. Pharmacokinetic properties of the synthetic cannabinoid JWH and of its metabolites in serum after inhalation. J Pharm Biomed Anal. Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH Gaoni Y, Mechoulam R. National Library of Medicine. Topical cannabinoids in dermatology.
Notes from the Field: Signs and symptoms associated with synthetic cannabinoid toxicity: A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Acute effects of synthetic cannabinoids: Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
Cohen K, Weinstein A. The Effects of Cannabinoids on Executive Functions: Global Drug Survey Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample.
Global speculations and recommendations for future Phase I trials. Lessons from the fatal French study BIA Inhibition of fatty acid amide hydrolase by BIA in rat brain. J Cereb Blood Flow Metab.
Welcome to ATG
The past year has seen a surge of interest in marijuana's CBD, leaves, and, only to a very minor extent, from the stalk of the hemp plant. So when there are discussions about hemp oil and CBD based vaping oils people CBD oil is derived from hemp stem or industrial hemp. However, the anti-cancer potential of CBD has not been translated into the clinic. . In addition, cell aliquots stained with trypan blue (%) were .. Low physiological oxygen culture is thought to be important for stem cell.